Clinical Trial Update: Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update studying rivaroxaban in children over 2 years with giant coronary artery aneurysms following Kawasaki disease. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Aneurysm
• Kawasaki Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Kawasaki Disease, Coronary Artery Aneurysm | Phase 4 | Status: RECRUITING